Posts
July 05 2011
Cell Therapeutics, Inc. announced the closing of their registered direct offering in the amount of $30,000,000. EG&S acted as counsel to the Placement Agent.
June 29 2011
BIOLASE Technology, Inc. announced the closing of their private placement in the amount of $9,000,000. EG&S acted as counsel to the Placement Agent.
June 28 2011
Ellenoff Grossman & Schole LLP was recognized by Chambers USA in its 2011 edition as a highly regarded law firm. Chambers USA ranks the leading firms and lawyers in an extensive range of practice areas throughout America. The research is in-depth and client-focused and the guide is read by industry-leading companies and organizations throughout the US and worldwide.
“The firm is small enough to be extremely responsive to its clients but large enough to have a number of extremely experienced M&A attorneys.”
June 27 2011
Trio Merger Corp. announced the completion of its initial public offering in the amount of $60,000,000. EG&S acted as counsel to the Underwriter.
June 27 2011
OncoSec Medical Incorporated announced the closing of their private placement in the amount of $3,000,000. EG&S acted as counsel to the Placement Agent.
June 23 2011
United Refining Company announced the closing of their exchange offer of 10.500% First Priority Senior Secured Notes for $365,000,000. EG&S acted as counsel to United Refining.
June 22 2011
Cleveland BioLabs, Inc. announced their registered direct offering in the amount of $23,492,000. EG&S acted as counsel to the Placement Agent.
June 22 2011
Stuart N. Neuhauser, a member of the Firm, was invited by IPO Vital Signs to comment on the resurgence of SPACs in the 2011 IPO market.